Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s interface revision/version label was updated from “v3.5.2” to “v3.5.3,” indicating a minor update to the ClinicalTrials.gov site software rather than a change to the trial record content.
    Difference
    0.0%
    Check dated 2026-04-24T16:44:17.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:31:30.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T18:59:17.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T14:58:53.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Version 3.4.2 (2026-02-03) adds Contacts/Locations and Study Status to the record history. The prior revision 3.4.0 (2025-10-06) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:42:36.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Added a glossary toggle and a color-coded change legend; updated revision to v3.4.0 and removed the No FEAR Act Data and the v3.3.4 entry.
    Difference
    0.5%
    Check dated 2026-01-27T22:37:46.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.